Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
175,611,455
-
Total 13F shares
-
86,235,505
-
Share change
-
+3,174,254
-
Total reported value
-
$5,705,096,962
-
Put/Call ratio
-
178%
-
Price per share
-
$66.41
-
Number of holders
-
354
-
Value change
-
+$229,301,575
-
Number of buys
-
209
-
Number of sells
-
133
Institutional Holders of Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC) as of Q2 2019
As of 30 Jun 2019,
Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC) was held by
354 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
86,235,505 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, JPMORGAN CHASE & CO, WELLINGTON MANAGEMENT GROUP LLP, JANUS HENDERSON GROUP PLC, ALLIANCEBERNSTEIN L.P., WADDELL & REED FINANCIAL INC, BANK OF AMERICA CORP /DE/, ZEVENBERGEN CAPITAL INVESTMENTS LLC, and RIVERBRIDGE PARTNERS LLC.
This page lists
356
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.